CV Lattes
Universidade do Vale do Paraíba (UNIVAP). Instituto de Pesquisa e Desenvolvimento (IP&D) (Institutional affiliation for the last research proposal) Birthplace: Brazil
I'm graduated in Biomedical science and PhD in Biomedical engineering, my research studies involve the neuroprotective effects of biodevices containing distinct drugs focusing on Alzheimer's disease therapy. I had a Science Without Borders Scholarship and I studied biomedical sciences at the University of Ulster, Northern Ireland (2012-2013). I primarily act on the following areas: Nanotechnology, utrathin fibers, anti diabetic drugs, Alzheimer's disease, type 2 diabetes, cancer, cell culture, photodynamic therapy, cell adhesion, led. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Alzheimer's Disease (AD) is a neurodegenerative pathology that affects 36 million people worldwide. Type 2 Diabetes Mellitus (T2DM) is a risk factor for AD, as this dementia has been linked to impaired insulin signalling in the brain, consequently, drugs that enhance this signalling may have therapeutic potential for AD. Several studies have shown that GLP-1 (glucagon-like peptide-1) and …
Photodynamic therapy (PDT) is a therapeutic modality for the treatment of neoplastic diseases and non-neoplastic characterized by overgrowth of unwanted or abnormal cells. This therapy involves the activation by light in the presence of molecular oxygen, certain dyes (photosensitizers) that are somehow selectively absorbed by the target tissue. This process has been used as a palliative t…
| 2 / 2 | Completed scholarships in Brazil |
| Associated processes | |